x,y,Name,Genes
32.417793,-25.305553,acetylation and deacetylation of rela in nucleus,CREBBP NFKBIA RELA HDAC3 EP300 
30.590923,-26.769438,actions of nitric oxide in the heart,GUCY1A3 GUCY1A2 HSP90AA1 NOS3 PDPK1 CAV1 VEGFA GNB1 PIK3R1 PIK3CA PRKAR1B PRKAR1A GNAQ PDE3B PDE3A GUCY2D RYR2 CHRNA1 GUCY2C GUCY1B3 FLT1 GUCY2F CHRM1 GUCY1B2 FLT4 CAMK2B SLC7A1 KNG1 PLN GNGT1 PRKACG PRKAR2B PRKAR2A AKT1 PDE2A KDR BDKRB2 PLCG1 PRKACB PRKG2 TNNI1 PRKG1 
32.047405,-22.979347,activation of camp-dependent protein kinase pka,EDN1 F2 AGT CXCL12 GNB1 PRKAR1B PRKAR1A AGTR2 GNAS CHRM1 PTGER1 ADCY1 CCL11 HTR2C FPR1 ADRB2 ADRA1B GNGT1 EDNRA PRKACG EDNRB CXCR4 PRKAR2B P2RY2 PRKAR2A CCL4 PRKACB CCR5 CCR3 
31.792606,-23.196615,activation of csk by camp-dependent protein kinase inhibits signaling through the t cell receptor,CREBBP EDN1 F2 AGT ZAP70 PTPRC LCK CXCL12 CD4 GNB1 PRKAR1B PRKAR1A AGTR2 HLA-DRA GNAS CD247 HLA-DRB1 CHRM1 TRB TRA PTGER1 ADCY1 CCL11 HTR2C FPR1 ADRB2 CD3G CD3E ADRA1B CD3D GNGT1 EDNRA PRKACG EDNRB CXCR4 PRKAR2B P2RY2 PRKAR2A CCL4 CSK PRKACB CCR5 CCR3 
30.39687,-26.4065,activation of pkc through g-protein coupled receptors,PPP1R14A EDN1 CXCL12 CCL11 GNAQ CCL4 PRKCB F2 PRKCA AGT PLCB1 
31.980452,-24.29432,adp-ribosylation factor,ARFGEF2 GPLD1 RALBP1 COP ARFGEF1 GBF1 ARAP1 ARAP2 ARFGAP3 ARFGAP1 KDELR3 COPA NCF2 KDELR1 ARF1 KDELR2 CLTB CLTA ASAP2 ARHGAP1 ARHGAP6 ARHGAP4 ARHGAP5 CYTH4 CYTH3 ASAP1 CHN1 CYTH2 CYTH1 
30.942247,-24.804897,agrin in postsynaptic differentiation,ITGA1 JUN LAMB3 NRG1 LAMB2 NRG2 NRG3 LAMB1 CDC42 PTK2 ACTA1 SP1 CTTN RAPSN UTRN ARHGEF6 AGRN ARHGEF7 CHRNA1 ITGB1 SRC CHRM1 PXN LAMA3 LAMA2 LAMA5 LAMA4 LAMC1 LAMC3 LAMA1 LAMC2 EGFR PAK2 PAK1 MAPK8 DVL1 MAPK3 PAK7 DAG1 RAC1 MAPK1 MUSK DMD PAK4 PAK3 PAK6 GIT2 
32.811157,-26.96416,akap95 role in mitosis and chromosome dynamics,DDX5 NPY4R H3F3A H3F3B AKAP8 PRKAG1 PPP2R5D PRKACG CCNB1 PRKAR2B PRKAR2A NCAPD2 CDK1 PRKACB 
32.16442,-24.051153,akt signaling pathway,RELA HSP90AA1 CHUK BAD PDPK1 FASLG FOXO4 FOXO3 GH1 PPP2CA FOXO1 NFKBIA GHR CASP9 PIK3R1 PIK3CA AKT1 YWHAH 
32.47843,-24.665554,alk in cardiac myocytes,TGFB1 TGFB3 SMAD5 TGFB2 MEF2C SMAD4 NOG SMAD1 RFC1 TGFBR1 SMAD6 BMP7 TGFBR2 BMP5 BMP4 BMP2 MYL2 BMPR1A ATF2 BMPR2 BMP10 CHRD GATA4 NPPA NPPB MAP3K7 NKX2-5 
30.97133,-26.841043,alternative complement pathway,C8G CFD C5 C6 C7 C9 C8A C8B CFP C3 
31.472982,4.244771,angiotensin ii mediated activation of jnk pathway via pyk2 dependent signaling,MAP2K4 MEF2A MEF2D MAP2K2 MAP3K1 JUN MEF2C MAP2K1 FOS PRKCB PRKCA AGT GNAQ AGTR1 GRB2 RAF1 BCAR1 SOS1 ATF2 SRC SHC1 CAMK2B ELK1 MEF2BNB-MEF2B EGFR CRKL PAK1 MAPK8 MAPK3 PTK2B PLCG1 RAC1 MAPK1 HRAS 
32.41281,-25.046553,antigen processing and presentation,CTSB CD74 HSP90AA1 KLRC3 HSPA5 KLRC4 TAP2 TAP1 TAPBP PSMB9 CD4 RFX5 HLA-DRA HLA-DQB1 KLRD1 CALR HLA-DQB2 KIR2DL1 KLK3 KIR2DL2 KIR2DL3 KIR2DL4 CTSS B2M HLA-DOB KIR2DL5A CIITA HLA-DQA2 HLA-DOA HLA-DQA1 PDIA3 IFNA13 IFNA14 HLA-DRB5 KIR2DS1 NFYB IFNA16 KIR2DS2 NFYC KIR2DS3 IFNA17 KIR2DS4 KIR2DS5 HLA-C RFXANK KIR3DL1 KIR3DL2 HLA-A HLA-B KIR3DL3 HLA-G HLA-E HLA-F CREB1 CD8B RFXAP CD8A CANX LGMN PSME2 LTA HLA-DPB1 PSME1 HLA-DRB4 HLA-DRB3 IFNA10 HLA-DRB1 IFNA6 IFNA5 IFNA8 IFNA7 IFNA2 HSP90AB1 IFNA1 IFNA4 IFI30 PSMB8 PSMB5 HLA-DMB PSMB6 HLA-DPA1 KLRC1 KLRC2 NFYA HLA-DMA IFNA21 
30.07084,-20.961231,apoptotic dna-fragmentation and tissue homeostasis,H1FOO DFFB ENDOG DFFA H1F0 CASP7 GZMB CASP3 HMGB1 H1FX HMGB2 
33.247383,-26.254278,apoptotic signaling in response to dna damage,APAF1 BAD CASP9 CASP6 CASP7 BCL2L1 AKT1 BCL2 BAX CASP3 ATM CYCS BID TP53 
30.556967,-25.781599,aspirin blocks signaling pathway involved in platelet activation,F2R MAP2K1 PLA2G4A PRKCB F2 PRKCA GNAI1 PTGS1 GNGT1 GNB1 TBXAS1 MAPK3 MAPK1 HRAS F2RL3 PLCB1 RAF1 
33.229683,-26.003994,atm signaling pathway,RELA JUN GADD45A BRCA1 RPA1 TP73 NFKBIA RAD51 MAPK8 CHEK1 CHEK2 ATM TREX1 ABL1 RBBP8 ATR TP53 MDM2 
31.031107,-26.807358,attenuation of gpcr signaling,PRKCB PRKCA GNGT1 PRKACG GRK4 GNB1 PRKAR1B ARRB1 PRKAR1A PRKAR2B PRKAR2A GNAS PRKACB 
31.30748,-25.466614,b cell survival pathway,CCT4 ITGA1 ITGB1 ZBTB7A PDPK1 MTOR PIK3R1 PIK3CA CASP7 DPF2 AKT1 BIRC5 CASP3 
31.580164,-27.01413,basic mechanism of action of ppara pparb(d) and pparg and effects on gene expression,RXRA PPARA PPARG PTGS1 PPARD 
32.585182,-24.416737,basic mechanisms of sumoylation,UBE2I SUMO2 SUMO1 SUMO3 UBA2 SAE1 
31.816782,-25.028715,bcr signaling pathway,LYN MAP3K1 JUN SYK CSNK2A1 MAP2K1 FOS PRKCB NFATC1 PRKCA VAV1 MAPK14 BCR BTK GRB2 RAF1 SOS1 SHC1 CAMK2B ELK1 PPP3CA CD79B PPP3CB CD79A PPP3CC MAPK8 MAPK3 BLNK PLCG1 RAC1 HRAS 
30.906858,-24.074556,bioactive peptide induced signaling pathway,STAT5B STAT1 STAT3 PRKCB PRKCA AGT MAPK14 GNB1 MAPT PIK3R1 PIK3CA CDK5 AGTR2 GRB2 SOS1 CAMK2D SHC1 CAMK2A CAMK2B GNAI1 MYLK GNGT1 MAPK8 GNA11 MAPK3 PTK2B PLCG1 MAPK1 HRAS FYN CAMK2G STAT5A JAK2 
32.88519,-24.670408,bone remodeling,RELA TNFRSF11A CHUK FOS FOSL2 IKBKB NFKBIA FOSL1 MAPK8 TRAF6 TNFSF11 IRF9 IFNB1 IKBKG IFNAR1 IFNAR2 
32.79032,-25.037539,brca1 dependent ub ligase activity,FANCD2 FANCA BRCA1 FANCC FANCF FANCE BARD1 FANCG 
32.19365,-27.013947,btg family proteins and cell cycle regulation,CHAF1A RB1 BTG2 CHAF1B BTG1 CCND1 PRMT1 HOXB9 TP53 
33.34922,-25.731771,ca-calmodulin-dependent protein kinase activation,CAMK2D CREB1 CAMK2A CAMK2B CAMK4 CAMK2G CAMKK1 CAMKK2 
30.706196,-26.260115,cadmium induces dna synthesis and proliferation in macrophages,RELA MAP2K2 JUN MAP2K1 FOS PRKCB TNF PRKCA CUZD1 NFKBIA MYC MAPK3 MAPK1 HRAS PLCB1 RAF1 
31.375572,4.495689,calcium signaling by hbx of hepatitis b virus,SRC JUN SHC1 CSNK2A1 MAP2K1 CAMK2B FOS CREB1 MAPK3 PTK2B HRAS GRB2 LAMTOR5 RAF1 SOS1 
32.81319,-24.955082,cardiac protection against ros,GPX1 GABRA3 GABRA2 GABRA1 GABRA6 GABRA5 GABRA4 PRKCE SOD3 SOD1 SOD2 
31.826899,-26.850397,carm1 and regulation of the estrogen receptor,GRIP1 GTF2A1 CREBBP POLR2A MEF2C EP300 GTF3A CARM1 GTF2F1 ESR1 GTF2E1 NR3C1 
30.164293,-20.832357,caspase cascade in apoptosis,SREBF1 DFFB DFFA APAF1 GZMB PARP1 LMNB1 PRF1 LMNB2 LMNA CASP8 CASP9 CASP6 CASP7 CASP10 ARHGDIB CASP4 XIAP CASP2 CASP3 CASP1 BIRC2 BIRC3 
29.07503,-24.05313,cbl mediated ligand-induced downregulation of egf receptors pathway,SRC EGF SH3KBP1 PRKCB PRKCA GRB2 CBL EGFR 
31.417662,-27.061625,ccr3 signaling in eosinophils,RHOA PPP1R12B LIMK1 CCL11 ROCK2 MAP2K1 PRKCB PIK3C2G PRKCA PTK2 GNGT1 GNB1 MYL2 GNAQ MAPK3 CFL1 GNAS MAPK1 HRAS DECR1 PLCB1 RAF1 CCR3 
32.36053,-27.251184,cd40l signaling pathway,NFKBIA RELA MAP3K1 CD40 TRAF6 TNFAIP3 TRAF3 CD40LG MAP4K4 
30.198494,-23.78183,cdc25 and chk1 regulatory pathway in response to dna damage,WEE1 RASGRF1 CHEK1 ATM CDK1 MYT1 YWHAH 
32.190388,-27.145538,cdk regulation of dna replication,CDT1 CDKN1B CDC6 ORC6 ORC5 KITLG ORC2 ORC1 CCNE1 ORC4 ORC3 CDK2 MCM4 MCM5 MCM6 MCM7 MCM2 MCM3 
33.106373,-25.186453,cell cycle: g1/s check point,TGFB1 SMAD3 SMAD4 CDKN2A CDKN2B CDC25A DHFR CCNA1 TFDP1 CDK6 CCNE1 CDK4 CDK2 ATM CDK1 ATR TP53 RB1 CDKN1B GSK3B HDAC1 CDKN1A CCND1 E2F1 ABL1 SKP2 
31.859816,-27.28666,cell cycle: g2/m checkpoint,CDKN2D RASGRF1 CDKN1A GADD45A BRCA1 PRKDC MYT1 WEE1 CDC34 CCNB1 RPS6KA1 CHEK1 EP300 CHEK2 PI4KA ATM CDK1 SFN YWHAH ATR TP53 MDM2 
31.333593,4.057726,cell to cell adhesion signaling,SRC ACTA1 PXN CDH1 CTNNB1 PTPN11 PECAM1 CTNNA1 CSK BCAR1 VCL PTK2 
29.60589,-23.408936,ceramide signaling pathway,MAP2K4 MAP2K2 MAP3K1 MAP2K1 KSR1 CHUK BAD CRADD TRAF2 TNFRSF1A MADD NFKBIA BCL2 BAX CYCS NSMAF BIRC3 RAF1 RELA TRADD TNF IKBKB CASP8 MAPK8 BAG4 SMPD1 AIFM1 MAPK3 FADD MAPK1 RIPK1 IKBKG MAP4K4 
32.598717,-27.030306,chaperones modulate interferon signaling pathway,RB1 RELA IFNGR1 CHUK LIN7A USH1C IKBKB NFKBIA WT1 FRA16A IFNG DNAJA3 CNTN2 HSPA1A TAX1BP3 IKBKG TP53 JAK2 
32.76144,-25.13639,chrebp regulation by carbohydrates and camp,EDN1 PKLR F2 PPP2R5D PRKAB1 PRKAB2 AGT CXCL12 GNB1 PRKAR1B MLXIPL PRKAR1A AGTR2 GNAS ACSBG1 PRKAA2 CHRM1 PTGER1 ADCY1 CCL11 ACSM1 PRKAG2 HTR2C FPR1 ADRB2 PRKAG1 ADRA1B PRKAA1 GNGT1 EDNRA PRKACG EDNRB CXCR4 PRKAR2B P2RY2 PRKAR2A CCL4 PRKACB CCR5 CCR3 
31.682512,-25.223091,chromatin remodeling by hswi/snf atp-dependent complexes,GTF2A1 SMARCD1 SMARCC1 SMARCC2 SMARCB1 GTF2B SMARCE1 GTF3A ARID1A GTF2F1 GTF2E1 NR3C1 SMARCA4 ACTB POLR2A NF1 
30.943596,-26.66545,classical complement pathway,C1QC C1QB C1QA C1R C1S C8A C8B C4A C2 C3 C8G C5 C6 C7 C9 
31.326612,-25.512827,control of gene expression by vitamin d receptor,NCOA2 MED1 CREBBP NCOA3 SMARCC1 SMARCC2 VDR NCOA1 SUPT16H ACTL6A SMARCE1 PRMT1 TSC2 ARID1A BAZ1B SMARCA4 NCOR1 SNW1 KAT2B COPS2 CARM1 TOP2B SMARCD1 HDAC1 CHAF1A RXRA EP300 
31.517128,-27.104279,control of skeletal myogenesis by hdac and calcium/calmodulin-dependent kinase (camk),CABIN1 HDAC5 CREBBP MEF2A MEF2D MEF2C PDPK1 CAMK2B MYOD1 NFATC1 MEF2BNB-MEF2B MAPK14 GRIP1 KAT2B PIK3R1 PIK3CA EP300 AKT1 AVP MAPK7 YWHAH 
31.930445,-23.116173,corticosteroids and cardioprotection,EDN1 ANXA1 HSP90AA1 NOS3 PDPK1 CAV1 F2 AGT CXCL12 GNB1 PIK3R1 PIK3CA GNAS RELA CCL11 CAMK2B ADRB2 NR3C1 KNG1 GNGT1 NPPA AKT1 CCL4 BDKRB2 CORIN 
31.30182,-26.749947,ctcf: first multivalent nuclear factor,TGFB1 CDKN1B TGFB3 SMAD5 TGFB2 SMAD4 CDKN2A SMAD1 PTEN PPP2R5D CTCF MTOR TGFBR1 SMAD6 TGFBR2 BCR CD79B CD79A PIK3R1 RPS6KB1 PIK3CA MYC MDM2 
30.887121,-25.761713,cxcr4 signaling pathway,GNGT1 CXCL12 GNB1 PIK3R1 PIK3CA CXCR4 GNAQ PLCG1 HRAS PIK3C2G GNAI1 
30.27346,-26.049679,cyclin e destruction pathway,RB1 FBXW7 TFDP1 CDC34 CCNE1 E2F1 CDK2 CUL1 SKP1 
31.234898,-26.949934,cycling of ran in nucleocytoplasmic transport,RANBP2 RANBP1 NUP214 NUP62 RCC1 NUP153 NUP210 RAN RANGAP1 
32.91205,-26.288994,cyclins and cell cycle regulation,RB1 CDKN2C CDKN1B CDKN2D CDKN2A CDKN1A CDKN2B CCNH CDC25A RBL1 CCNA1 TFDP1 CCND3 CDK7 CCNB1 CDK6 CCND2 CCND1 CCNE1 CDK4 E2F1 CDK2 CDK1 
31.445923,-26.644352,cystic fibrosis transmembrane conductance regulator (cftr) and beta 2 adrenergic receptor (b2ar) pathway,EDN1 ADCY1 CCL11 ADRB2 F2 AGT SLC9A3R1 GNGT1 PRKACG CXCL12 GNB1 PRKAR1B PRKAR1A PRKAR2B PRKAR2A CCL4 GNAS PRKACB EZR CFTR 
32.98383,-25.385006,d4gdi signaling pathway,RHOA JUN ARHGDIB CASP3 CASP1 ARHGAP5 
32.86497,-25.648611,deregulation of cdk5 in alzheimers disease,APP GSK3B MAPT CDK5 CAPN1 PPP2R5D CDK5R1 
32.291695,-24.412117,double stranded rna induced gene expression,RELA IFNA1 CHUK EIF2AK2 EIF2S3 EIF2S2 EIF2S1 IKBKB NFKBIA DNAJC3 IFNB1 IKBKG MAP4K4 TP53 
31.494278,-19.80524,downregulated of mta-3 in er-negative breast tumors,HDAC1 GREB1 MBD3 PDZK1 ESR1 TUBA1A TUBA3C HSPB1 TUBA4B TUBA4A TUBA8 TUBA1C CDH1 SNAI2 SNAI3 SNAI1 MTA3 ALDOA GAPDH CTSD 
30.833103,-26.141344,e2f1 destruction pathway,RB1 CCNA1 TFDP1 CDC34 CCNE1 E2F1 CDK2 CUL1 SKP1 SKP2 
30.140461,-24.565416,effects of calcineurin in keratinocyte differentiation,CDKN1A CAMK2B PRKCB NFATC1 PRKCA PPP3CA PPP3CB PPP3CC SP1 MARCKS SP3 GNAQ PLCG1 
31.330292,4.424307,egf signaling pathway,MAP2K4 EGF MAP3K1 STAT1 SHC1 MAP2K1 STAT3 PRKCB PRKCA ELK1 EGFR RASA1 MAPK8 PIK3R1 PIK3CA PLCG1 HRAS GRB2 JAK1 SOS1 
32.496723,-27.035915,eicosanoid metabolism,PTGFR PTGIS EPHX1 PLA2G1B PTGER1 PTGIR PTGER2 PTGER3 EPHX2 PTGER4 ALOX5AP MPO PTGS1 HPGDS CYSLTR2 TBXA2R CYSLTR1 TBXAS1 ALOX5 COX2 PTGES PLCB1 CYP2J2 
30.47622,-24.514418,endocytotic role of ndk phosphins and dynamin,CAMK2B AP2A1 DNM1 EPN1 NME1 NME2 PPP3CA PICALM PPP3CB PPP3CC SYNJ2 SYNJ1 BIN2 BIN1 EPS15 AP2M1 
32.91739,-26.89898,epo signaling pathway,STAT5B EPO SHC1 PLCG1 HRAS GRB2 PTPN6 EPOR STAT5A SOS1 JAK2 
30.818666,-23.18243,er associated degradation (erad) pathway,UBE2I EDEM1 FBXO2 CUL1 MOGS RBX1 GANAB MAN2A2 SEC61A1 MAN1B1 MAN2C1 CANX MAN1C1 MAN1A2 MAN2B1 MAN1A1 UGGT1 SKP1 SAE1 
33.0862,-26.025589,erk and pi-3 kinase are necessary for collagen binding in corneal epithelia,GSN ITGA1 RHOA ACTN4 MAP2K1 ACTN3 ACTN2 ACTN1 PTK2 DIAPH1 ACTA1 PIK3R1 PIK3CA ZYX TLN1 PFN1 BCAR1 VCL ITGB1 SRC ROCK1 PXN MLC1 MYLK ARHGAP5 TNS1 MAPK3 PLCG1 MAPK1 CAPN1 CSK 
29.855145,-13.604024,erk1/erk2 mapk signaling pathway,NGFR SRC MAP2K2 SHC1 MAP2K1 PTPRR STAT3 PPP2R5D ELK1 NGF RPS6KA5 RPS6KA1 MKNK1 TERT MKNK2 MYC MAPK3 MAPK1 HRAS GRB2 RAF1 SOS1 
32.930477,-26.65799,erythropoietin mediated neuroprotection through nf-kb,RELA EPO JUN CDKN1A ARNT HIF1A EPOR SOD2 COPS5 NFKBIA CREB1 EP300 JAK2 
32.07704,-27.117556,estrogen responsive protein efp controls cell cycle and breast tumors growth,SMURF1 ESR1 CDK8 CCNB2 CDK7 CCNB1 CDK6 CDK5 CDK4 CDK3 CDK2 TRIM25 CDK1 SFN TP53 
32.95736,-26.77562,eukaryotic protein translation,EIF5B EIF4A2 EIF3A EIF4A1 EIF1AX EIF2S3 EIF2S2 EIF2S1 EIF5 EIF6 EIF4G1 EIF4E EIF4G3 EIF4G2 
29.03489,-18.889334,extrinsic prothrombin activation pathway,FGB ZFHX3 FGG F2R F10 PROS1 F2 F3 TFPI F5 F7 PROC FGA 
33.160645,-26.389963,fas signaling pathway (cd95),MAP2K4 RB1 MAP3K1 DAXX FAF1 CFLAR PRKDC PTPN13 FASLG CASP8 PAK2 PAK1 MAPK8 CASP7 CASP10 FAS CASP3 FADD RIPK2 MAP3K7 
31.976305,-27.032255,fc epsilon receptor i signaling in mast cells,MAP2K4 LYN MAP2K2 MAP3K1 JUN SYK MAP2K1 FOS PRKCB VAV1 PIK3R1 PIK3CA BTK GRB2 MS4A2 RAF1 SOS1 SHC1 PLA2G1B ELK1 PAK2 MAPK8 MAPK3 FCER1A PLCG1 MAPK1 HRAS FCER1G MAP2K7 
29.217354,-18.745602,fibrinolysis pathway,FGB SERPINB2 ZFHX3 CPB2 FGG F2R SERPINE1 F13A1 UBE2A PLAU F2 PLAT PLG UBA1 FGA 
29.987257,-24.971428,fmlp induced chemokine gene expression in hmc-1 cells,MAP2K2 MAP2K3 MAP2K1 PRKCB NFATC1 PRKCA MAPK14 NFKBIA GNB1 PLCB1 RAF1 RELA NCF2 CAMK2B FPR1 PIK3C2G ELK1 CAMKK1 CAMKK2 PPP3CA GNA15 GNGT1 PPP3CB PPP3CC PAK1 MAPK3 RAC1 MAPK1 HRAS MAP2K6 
33.20538,-25.334524,fosb gene expression and drug abuse,GRIA2 JUND PPP1R1B CDK5 FOSB 
32.987534,-26.764914,g-protein signaling through tubby proteins,GNGT1 TUB EDN1 CXCL12 GNB1 CCL11 GNAQ CCL4 F2 AGT 
28.67244,-21.306114,g-secretase mediated erbb4 signaling pathway,ADAM17 ERBB4 NRG4 PRKCB PSEN1 NRG2 PRKCA NRG3 
31.35679,-19.606709,gamma-aminobutyric acid receptor life cycle pathway,GABRA3 GABRA2 NSF GABARAP SRC GABRA1 GABRA6 GABRA5 GABRA4 UBE3A UBE2A DNM1 GPHN UBQLN1 UBA1 
29.988495,-24.807053,gata3 participate in activating the th2 cytokine genes expression,MAP2K3 ADCY1 IL13 NFATC1 GATA3 MAPK14 IL1A MAF IL5 IL4 PRKACG PRKAR1B PRKAR1A PRKAR2B PRKAR2A GNAS JUNB PRKACB MAP2K6 
30.027302,-21.01554,granzyme a mediated apoptosis pathway,SET CREBBP DFFB DFFA ANP32A GZMB GZMA APEX1 CASP3 PRF1 HMGB2 NME1 
31.55062,-26.527267,growth hormone signaling pathway,STAT5B INSR IRS1 SHC1 CISH SLC2A14 SRF PRKCB PRKCA INS GH1 GHR RPS6KA1 HNF1A PIK3R1 PIK3CA PLCG1 GRB2 PTPN6 STAT5A SOS1 JAK2 
32.754444,-25.860767,hemoglobins chaperone,FECH ALAS2 ALAS1 HBB UROS HBA1 CPOX HBA2 GATA1 ALAD HMBS UROD AHSP 
31.697704,-26.790596,hiv-1 nef: negative effector of fas and tnf,GSN MAP3K1 APAF1 CRADD CFLAR TNFRSF1A NFKBIA RASA1 FAS BCL2 CYCS RB1 RELA TRADD LMNB1 TNF LMNB2 LMNA CASP8 PAK2 CASP9 CASP6 CASP7 CASP2 CASP3 FADD RIPK1 MAP3K5 DFFB CDK11B DFFA DAXX PRKCD CHUK PARP1 TRAF1 TRAF2 PTK2 MAP3K14 BIRC2 BIRC3 MDM2 NUMA1 PSEN1 PRKDC PSEN2 FASLG MAPK8 BAG4 ARHGDIB SPTAN1 BID MAP2K7 
32.178333,-25.348583,how does salmonella hijack a cell,ARPC1A ACTR3 ACTR2 ARPC3 ARPC4 ARPC2 ARPC1B RAC1 WASL WASF1 CDC42 
32.34832,-25.670818,how progesterone initiates the oocyte maturation,CAP1 SRC PAQR5 ADCY1 MYT1 GNAI1 CDC25C GNGT1 PRKACG CCNB1 GNB1 PRKAR1B PRKAR1A PRKAR2B PRKAR2A MAPK3 GNAS CDK1 MAPK1 HRAS PGR PRKACB PIN1 
29.843145,-24.53525,human cytomegalovirus and map kinase pathways,RB1 RELA MAP2K2 MAP3K1 MAP2K3 MAP2K1 PDPK1 MAPK14 CREB1 SP1 PIK3R1 PIK3CA AKT1 MAPK3 MAPK1 MAP2K6 
31.127493,-25.952148,hypoxia and p53 in the cardiovascular system,ABCB1 HSP90AA1 CDKN1A GADD45A FHL2 IGFBP3 UBE2A RPA1 HIF1A HIC1 NFKBIB TAF1 DNAJB1P1 MAPK8 EP300 AKT1 HSPA1A BAX ATM TP53 MDM2 
30.782116,-25.542774,hypoxia-inducible factor in the cardivascular system,EDN1 EPO JUN HSP90AA1 NOS3 ARNT UBE2A HIF1A VEGFA COPS5 CREB1 LDHA EP300 ASPH VHL P4HB 
30.916758,-25.201063,ifn alpha signaling pathway,STAT1 ST13 IFNA1 STAT2 IFNB1 TYK2 IFNAR1 JAK1 IFNAR2 
32.49229,-25.98677,ifn gamma signaling pathway,FRA16A STAT1 IFNGR1 IFNG JAK1 JAK2 
30.653097,-26.234041,igf-1 signaling pathway,JUN IRS1 SHC1 CSNK2A1 MAP2K1 SRF FOS PTPN11 IGF1 ELK1 IGF1R RASA1 MAPK8 PIK3R1 PIK3CA MAPK3 HRAS GRB2 RAF1 SOS1 
31.360718,-24.410086,il 2 signaling pathway,STAT5B SHC1 SYK IL2RG IL2 LCK IL2RA IL2RB HRAS GRB2 JAK3 JAK1 STAT5A SOS1 
30.849009,-23.760185,il 3 signaling pathway,STAT5B SHC1 IL3RA FOS HRAS GRB2 CSF2RB PTPN6 IL3 STAT5A SOS1 JAK2 
31.636114,-26.875195,il 4 signaling pathway,IL4R SHC1 IL2RG HMGA1 IL4 RPS6KB1 AKT1 HLA-DRA IGHE STAT6 GRB2 JAK3 JAK1 FCER2 HLA-DRB1 
30.873169,-26.17828,il 6 signaling pathway,CEBPB SHC1 STAT3 PTPN11 LRPPRC IL6 HRAS GRB2 JAK3 IL6R JAK1 SOS1 JAK2 
31.392612,-24.825567,il-10 anti-inflammatory signaling pathway,IL10 IL10RB IL10RA TNF MAPK14 IL1A IL6 HMOX1 MAP3K5 JAK1 BLVRB MAP2K6 BLVRA 
32.462185,-26.941639,il-2 receptor beta chain in t cell activation,BAD NMI IL2 PPIA PIK3CA FAS BCL2 PTPN6 RAF1 SOS1 PCNA RB1 SHC1 CCNH IL2RG SOCS3 CRKL SOCS1 CCND3 CCND2 CCND1 E2F1 MYC AKT1 STAT5B MAP2K2 MAP2K1 PDPK1 FOS CCNA1 TFDP1 PIK3R1 RPS6KB1 IL2RA CCNE1 IL2RB BCL2L1 GRB2 IRS1 FASLG IKZF3 CBL CCNB1 MAPK3 MAPK1 HRAS JAK3 JAK1 STAT5A 
31.342161,-24.436077,il-7 signal transduction,STAT5B CREBBP ITGA2B NMI IL2RG LCK PIK3R1 PIK3CA EP300 PTK2B BCL2 FYN JAK3 JAK1 STAT5A 
30.756426,-25.228798,il12 and stat4 dependent signaling pathway in th1 development,JUN STAT4 TYK2 ETV5 MAPK14 MAPK8 IFNG IL12B IL12A IL12RB2 IL12RB1 CCR5 MAP2K6 IL18R1 JAK2 
30.99314,-23.981253,il22 soluble receptor signaling pathway,SOCS3 IL22RA2 IL22 STAT5B IL22RA1 STAT1 STAT3 IL10RA TYK2 JAK1 STAT5A 
28.926317,-22.449638,inactivation of gsk3 by akt causes accumulation of b-catenin in alveolar macrophages,FZD1 CSNK2A1 CHUK PDPK1 EIF2AK2 KREMEN2 TIRAP AXIN1 PPP2R5D DKK1 DKK2 PROC MYD88 NFKBIA PIK3R1 PIK3CA TOLLIP TLR4 LEF1 RELA GSK3B CTNNB1 LRP6 EHHADH LY96 NKD1 NKD2 IKBKB FRAT1 GJA1 WIF1 CCND1 DVL1 IRAK1 AKT1 WNT1 CD14 IKBKG BTRC 
32.551666,-26.550573,induction of apoptosis through dr3 and dr4/5 death receptors,DFFB DFFA PARP1 TRADD TNFRSF10B TNFRSF10A TRAF2 LMNA CASP8 ACTA1 CASP6 CASP7 CASP10 GAS2 CASP3 TNFSF12 FADD TNFSF10 RIPK1 MAP3K14 SPTAN1 TNFRSF25 BID 
31.482283,4.6474323,influence of ras and rho proteins on g1 to s transition,RHOA MAP2K2 MAP2K1 CHUK PDPK1 NFKBIA TFDP1 CDK6 PIK3R1 PIK3CA CCNE1 CDK4 CDK2 RAF1 RB1 RELA CDKN1B CDKN1A IKBKB PAK1 CCND1 E2F1 AKT1 MAPK3 RAC1 MAPK1 HRAS IKBKG 
31.359539,4.4069986,inhibition of cellular proliferation by gleevec,STAT5B MAP2K4 MAP3K1 JUN STAT1 MAP2K1 FOS CRKL BCR MAPK8 PIK3R1 PIK3CA MYC AKT1 MAPK3 BCL2 HRAS GRB2 STAT5A RAF1 SOS1 JAK2 
31.552746,-25.598373,inhibition of matrix metalloproteinases,MMP14 MMP2 TIMP3 TIMP4 TIMP1 TIMP2 MMP9 RECK 
31.669348,3.8586993,insulin signaling pathway,PTPN1 G6PC BAD RPS6 TSC2 TSC1 PRKAB1 PRKAB2 PPP1CA PPP1CB GCK MAPK10 PPP1R3D PPP1R3C CALM2 CALM3 RAF1 CALM1 PRKAA2 CALML6 CALML3 CBLC PPP1R3B PRKY PPP1R3A ARAF PRKX CBLB PRKAA1 FOXO1 PPP1CC CRKL NRAS AKT3 AKT1 AKT2 PPARGC1A SH2B2 SREBF1 INSR MAP2K2 PRKCI MAP2K1 PHKA2 PHKB PHKA1 PRKCZ RHEB PIK3R1 PRKAR1B FASN PRKAR1A GRB2 IRS1 IRS2 EIF4EBP1 SLC2A4 IRS4 ELK1 INPP5D PRKACG LIPE PRKAR2B PRKAR2A FLOT2 FLOT1 PRKACB PRKACA PTPN11 BRAF G6PC2 PTPRF RHOQ PIK3CB PIK3CA PDE3B PDE3A EXOC7 RAPGEF1 SOS2 FBP1 FBP2 SOS1 SHC3 GSK3B SHC4 SHC1 SHC2 PIK3R5 PIK3R3 PIK3R2 ACACB ACACA SOCS3 SOCS4 SOCS1 SOCS2 MKNK1 MKNK2 PCK2 PCK1 PKLR PDPK1 SLC2A14 SORBS1 PFKM PFKL RPS6KB2 RPS6KB1 CRK KRAS PFKP TRIP10 PYGB PRKAG2 PYGL PRKAG3 PIK3CD PYGM PRKAG1 INS CBL GYS1 PIK3CG GYS2 IKBKB MAPK9 MAPK8 PHKG2 PHKG1 MAPK3 MAPK1 HRAS 
31.357752,-26.389778,integrin signaling pathway,ITGA1 RHOA PPP1R12B ACTN4 ACTN3 ACTN2 CAV1 ACTN1 PTK2 BCR ACTA1 ZYX RAPGEF1 GRB2 TLN1 BCAR1 VCL SOS1 ITGB1 SRC ROCK1 SHC1 PXN MLC1 NOLC1 LRPAP1 TNS1 CRKL MAPK8 CAPN1 HRAS CSK FYN 
32.907547,-25.93106,internal ribosome entry pathway,EIF3A EIF4A1 PTBP1 PTBP2 CASP8 CASP9 CASP6 CASP7 CASP10 CASP4 CASP5 CASP2 EIF4G1 CASP3 CASP1 EIF4E EIF4G3 EIF4G2 
29.042463,-18.898941,intrinsic prothrombin activation pathway,FGB ZFHX3 FGG F11 F2R F10 F12 PROS1 F2 F5 KNG1 PROC F8 COL4A1 F9 COL4A3 COL4A2 COL4A5 COL4A4 SERPING1 COL4A6 KLKB1 FGA 
31.921366,-23.066202,ion channels and their functional role in vascular endothelium,GUCY1A3 EDN1 GUCY1A2 TRPC6 HSP90AA1 TRPC4 NOS3 TRPC5 TRPC3 CAV1 TRPV4 F2 AGT CXCL12 GNB1 KCNQ2 KCNQ3 KCNQ4 AGTR2 KCNQ5 GNAS GUCY1B3 CHRM1 GUCY1B2 PTGER1 ADCY1 CCL11 CAMK2B HTR2C FPR1 ADRB2 ADRA1B KNG1 GNGT1 EDNRA EDNRB CXCR4 P2RY2 AKT1 CCL4 BDKRB2 CCR5 PRKG2 CCR3 PRKG1 
30.187546,-24.775028,keratinocyte differentiation,EGF MAP3K1 JUN PPP2R5D TNFRSF1A MAPK13 MAPK14 NFKBIA SP1 FAS BCL2 RAF1 SOS1 RELA SHC1 TNF EGFR RIPK1 HOXA7 MAP3K5 MAP2K4 PRKCH PRKCG MAP2K2 MAP2K3 DAXX PRKCD MAP2K1 CHUK PRKCE TRAF1 FOS PRKCB TRAF2 PRKCA PRKCQ GRB2 BIRC2 BIRC3 CEBPA PLAT FASLG ETS1 ETS2 IKBKB MAPK8 MAPK3 MAPK1 HRAS IKBKG MAP4K4 MAP2K6 MAP2K7 
31.65339,-23.312685,lck and fyn tyrosine kinases in initiation of tcr activation,TRB TRA CD3G CD3E CD3D ZAP70 PTPRC LCK CD4 HLA-DRA FYN CD247 HLA-DRB1 
31.037668,-26.506405,lectin induced complement pathway,MASP1 C8A C8B C4A C2 C3 C8G C5 C6 C7 C9 MASP2 MBL2 
31.419136,4.1893525,links between pyk2 and map kinases,MAP2K4 MAP2K2 MAP3K1 MAP2K3 JUN MAP2K1 PRKCB PRKCA MAPK14 GNAQ GRB2 RAF1 BCAR1 SOS1 SRC SHC1 CAMK2B CRKL PAK1 MAPK8 MAPK3 PTK2B PLCG1 RAC1 MAPK1 HRAS 
32.5514,-24.869705,lissencephaly gene (lis1) in neuronal migration and development,DCTN6 DNAH5 DYNLL1 DNAH3 DCTN3 DNAH8 CSNK2A1 DCTN2 DNAH6 DCTN1 LRP8 RELN CLIP1 CDK5 NDEL1 PAFAH1B1 DCX ABL1 CDK5R1 DNAH1 
31.469057,4.560123,map kinase inactivation of smrt corepressor,MAP2K4 EGF MAP3K1 SHC1 THRB MAP2K1 THRA ZBTB16 EGFR MAPK14 RXRA NCOR2 RAC1 HRAS RARA GRB2 SOS1 
29.433083,-24.926155,mapkinase signaling pathway,MAP3K3 MAP3K4 MAP3K1 JUN MAP3K2 MAPK13 GCK MAPK14 MAPK11 MAPK12 SP1 MAPK10 RAF1 ATF2 ARAF MEF2BNB-MEF2B PAK2 PAK1 MYC MAP3K7 MAP3K8 MAP3K5 MAP2K4 MEF2A MAP2K5 MAP4K3 MEF2D MAP2K2 MAP2K3 MAP4K1 MEF2C STAT1 MAP2K1 CHUK FOS CREB1 MAP3K11 MAP3K14 MAP3K12 MAP3K13 CEBPA MAX ELK1 IKBKB MAPK9 MAPK8 RPS6KA1 MAPK3 RAC1 MAPK1 HRAS MAPK7 MAP4K4 MAP2K6 MAP2K7 MAP4K5 
32.65123,-26.504461,mcalpain and friends in cell motility,ITGA1 CAST EGF MAP2K2 MAP2K1 PTK2 ACTA1 PRKAR1B PRKAR1A GRB2 TLN1 EZR SOS1 ITGB1 SHC1 PXN MLC1 EGFR MYLK PRKACG PRKAR2B CAPNS1 PRKAR2A MAPK3 RAC1 MAPK1 CAPN1 HRAS CAPN2 PRKACB 
31.360327,-26.517836,mechanism of acetaminophen activity and toxicity,NR1I3 CYP1A2 COX3 COX2 CYP2E1 PTGS1 CYP3A 
32.152912,-25.036898,mechanism of gene regulation by peroxisome proliferators via ppara,MED1 DUT JUN NCOA1 HSP90AA1 DUSP1 APOA2 NFKBIA NCOR1 SP1 NCOR2 APOA1 ACOX1 HSPA1A RB1 RELA CITED2 HSD17B4 EHHADH TNF RXRA NRIP1 MYC ME1 PPARGC1A STAT5B CREBBP CPT1A PPARA NR1H3 NR2F1 PRKCB NR0B2 PRKCA PRKAR1B PRKAR1A FAT1 FRA8B FABP1 LPL SRA1 MRPL11 PRKACG PRKAR2B EP300 PRKAR2A MAPK3 MAPK1 COX2 NOS2 PRKACB STAT5A 
32.75666,-25.527182,mechanism of protein import into the nucleus,RANBP2 KPNB1 RANBP1 NUP214 NUP62 RCC1 NUP153 NUP210 NUTF2 RAN KPNA2 RANGAP1 
31.641962,-23.776997,mechanisms of transcriptional repression by dna methylation,HDAC1 HDAC2 MBD1 MBD2 MBD3 CHD4 CHD3 SAP30 MECP2 MTA2 SIN3B SIN3A RBBP4 SAP18 RBBP7 
32.96222,-25.485796,melanocyte development and pigmentation pathway,MAP2K2 MAP2K1 MITF CREB1 KITLG RPS6KA1 KIT EP300 MAPK3 BCL2 MAPK1 HRAS RAF1 
32.058422,-26.66873,metabolism of anandamide an endogenous cannabinoid,FAAH CNR2 CNR1 PLD2 PLD1 BAAT PLD3 
32.24679,-26.59727,mets affect on macrophage differentiation,CSF1R HDAC5 JUN CSF1 HDAC2 FOS ETV3 DDX20 ETS1 ETS2 RBL1 NCOR2 RBL2 SIN3B SIN3A E2F1 E2F4 HRAS 
31.465618,-26.463686,mtor signaling pathway,RPS6 VEGFC TSC2 TSC1 BRAF PPP2R5D VEGFA GH1 VEGFB PIK3CB PIK3CA ULK3 ULK2 ULK1 FIGF EIF4B PRKAA2 PIK3R5 PIK3R3 PIK3R2 PRKAA1 GHR MKNK1 AKT3 AKT1 AKT2 EIF4E EIF3A PDPK1 IGF1 MTOR PGF FKBP1A RHEB PIK3R1 RPS6KB2 RPS6KB1 DDIT4 EIF4G1 EIF4A1 IRS1 CAB39 EIF4EBP1 PTEN PIK3CD HIF1A INS PIK3CG STK11 RPS6KA6 RPS6KA1 RPS6KA3 RPS6KA2 MAPK3 MAPK1 RICTOR PDK2 
31.21093,-25.483374,multi-drug resistance factors,ABCB4 ABCB1 ABCB11 ABCC3 GSTP1 ABCC1 
28.97536,-22.247383,multi-step regulation of transcription by pitx2,MED1 CREBBP FZD1 CSNK2A1 KREMEN2 AXIN1 PPP2R5D DKK1 DKK2 PROC LEF1 GSK3B HDAC1 TRRAP LDB1 CTNNB1 LRP6 NKD1 NKD2 FRAT1 CCND2 WIF1 KAT5 DVL1 EP300 WNT1 PITX2 
31.78993,-25.781448,multiple antiapoptotic pathways from igf-1r signaling lead to bad phosphorylation,IRS1 SHC1 BAD IGF1 IGF1R PIK3R1 PIK3CA MAPK3 HRAS GRB2 YWHAH RAF1 SOS1 
29.784252,-13.53591,nerve growth factor pathway (ngf),NGFR JUN SHC1 CSNK2A1 MAP2K1 FOS ELK1 NGF MAPK8 PIK3R1 PIK3CA MAPK3 PLCG1 HRAS GRB2 RAF1 SOS1 
28.757734,-21.382278,neuroregulin receptor degredation protein-1 controls erbb3 receptor recycling,ERBB3 UBE2D1 NRG1 NRG2 NRG3 RNF41 
31.999027,-24.67022,nf-kb signaling pathway,RELA MAP3K1 IL1R1 CHUK TRADD TNF NFKB1 TNFRSF1A IL1A IKBKB MYD88 NFKBIA TRAF6 IRAK1 FADD RIPK1 MAP3K7 IKBKG TAB1 MAP4K4 TLR4 
32.71118,-26.4437,nfat and hypertrophy of the heart ,CREBBP EDN1 MEF2C PDPK1 LIF IGF1 NFATC1 ELSPBP1 ALOX15B ACTA1 HAND1 PIK3R1 RPS6KB1 PIK3CA MYL2 HAND2 CAMK4 GRB2 CALR HBEGF SOS1 HDAC5 GSK3B SHC1 CTF1 CAMK2B ATP2A3 ATP2A2 TNF ATP2A1 GATA4 HDAC9 CAMKK1 CAMKK2 PPP3CA PPP3CB PPP3CC MAPK8 NPPA AKT1 HRAS ADSS NKX2-5 YWHAH 
31.665169,-24.811602,nfkb activation by nontypeable hemophilus influenzae,TGFB1 SMAD3 CREBBP TGFB3 MAP2K3 TGFB2 SMAD4 DUSP1 CHUK MUC5AC TGFBR1 TGFBR2 MAPK14 MAPK11 TLR2 IL1B MYD88 NFKBIA CXCL8 RELA TNF NR3C1 IKBKB MUC2 EP300 MAP3K7 IKBKG MAP4K4 MAP2K6 
30.512917,-24.432537,nitric oxide signaling pathway,CAMK2B PRKCB PRKCA GRIN2D GRIN2C GRIN1 PPP3CA PPP3CB PRKACG GRIN2B PPP3CC GRIN2A DLG4 PRKAR1B PRKAR1A PRKAR2B PRKAR2A NOS1 PRKACB 
30.738096,-25.476871,no2-dependent il-12 pathway in nk cells,STAT4 IFNG IL12B IL12A NOS2 IL12RB2 TYK2 IL12RB1 JAK2 
31.258831,-25.955109,nuclear receptors coordinate the activities of chromatin remodeling complexes and coactivators to facilitate initiation of transcription in carcinoma cells,NCOA2 GTF2A1 NCOA3 HDAC3 NCOA1 GTF2B GTF3A GTF2F1 GTF2E1 NR3C1 RXRA KAT2B NCOR2 POLR2A RARA 
29.941448,-24.261692,overview of telomerase protein component gene htert transcriptional regulation,WT1 MAX SP1 MXD1 MZF1 HDAC1 TERT MYC ESR1 TP53 
29.875168,-24.44672,overview of telomerase rna component gene hterc transcriptional regulation,RB1 SP1 SP3 NFYB NFYC TERC NFYA 
31.758411,-26.572844,oxidative stress induced gene expression via nrf2,JUN KEAP1 FOS PRKCB PRKCA AKR7A2 CRYZ MAFF CREB1 POR FXYD2 GSTA2 MAFG HMOX1 UGT1A6 HMOX2 MAFK NFE2L2 
31.518246,-25.96831,p38 mapk signaling pathway,MAP2K4 MEF2A MEF2D MAP3K1 MEF2C STAT1 H3F3A H3F3B CDC42 MAPK14 CREB1 MAPKAPK5 MAPKAPK2 DDIT3 ATF2 MAX PLA2G1B ELK1 MEF2BNB-MEF2B NR2C2 HSPB1 RPS6KA5 MKNK1 MYC RAC1 MAP3K9 HRAS MAP3K5 MAP2K6 HMGN1 
31.249529,-25.890556,p53 signaling pathway,APAF1 TSC2 CDK6 TP53I3 RRM2B CDK4 FAS CCNG2 CDK2 CCNG1 BCL2 BAX ATM CYCS STEAP3 ATR TP53 PCNA RB1 EI24 CD82 SERPINE1 RCHY1 BBC3 CASP8 CCND3 CASP9 CCND2 CHEK1 CCND1 E2F1 CHEK2 PERP TIMP3 BAI1 CASP3 RPRM GTSE1 SIAH1 SERPINB5 RRM2 CDKN2A GADD45B GADD45A IGFBP3 GADD45G IGF1 TNFRSF10B DDB2 TP73 PPM1D RFWD2 CCNE2 CCNE1 MDM4 MDM2 CDKN1A PTEN THBS1 CCNB3 SESN1 CCNB2 CCNB1 ZMAT3 SESN2 SESN3 PMAIP1 SFN BID 
30.957047,-23.836954,pdgf signaling pathway,MAP2K4 PDGFRA MAP3K1 JUN STAT1 CSNK2A1 MAP2K1 STAT3 FOS PRKCB PRKCA RASA1 PIK3R1 PIK3CA GRB2 RAF1 SOS1 SHC1 SRF PDGFA ELK1 MAPK8 MAPK3 PLCG1 HRAS JAK1 
32.408245,-26.575607,pelp1 modulation of estrogen receptor activity,PELP1 CREBBP SRC EP300 ESR1 
31.831081,-25.62781,pertussis toxin-insensitive ccr5 signaling in macrophage,CXCL12 JUN CXCR4 GNAQ CCL4 FOS PLCG1 CCL2 CCR5 
32.045406,-26.064398,phosphoinositides and their downstream targets,LYN GSK3B GSK3A ARF1 BAD PDPK1 PRKCE GTF3A VAV2 EEA1 PRKCZ PFKM PFKL RPS6KB1 AKT1 BTK PLCG1 RAC1 GRASP RAB5A PFKP 
31.087217,-26.161436,phospholipase c signaling pathway,PIK3R1 PIK3CA PDPK1 PLCG1 PLCB1 
32.36293,-25.968073,phospholipase c-epsilon pathway,PRKACG RAP2B PTGER1 PRKAR1B PRKAR1A PRKAR2B PRKAR2A PLCE1 GNAS RAPGEF3 ADRB2 PRKACB 
32.12828,-25.404373,phospholipids as signalling intermediaries,PDGFRA MAP2K2 SPHKAP MAP2K1 PDPK1 SPHK1 PRKCB PRKCA PTK2 GNB1 PIK3R1 PIK3CA GRB2 RAF1 SOS1 SRC SHC1 ADCY1 ITGB3 PDGFA PIK3C2G GNAI1 ASAH1 GNGT1 SMPD2 SMPD1 AKT1 MAPK3 S1PR1 RAC1 MAPK1 HRAS ITGAV 
29.80913,-13.514876,phosphorylation of mek1 by cdk5/p35 down regulates the map kinase pathway,NGFR EGR1 MAP2K2 SHC1 MAP2K1 NGF CDK5 MAPK3 MAPK1 HRAS GRB2 CDK5R1 RAF1 SOS1 
31.651812,-25.65342,pkc-catalyzed phosphorylation of inhibitory phosphoprotein of myosin phosphatase,PPP1R14A PPP1R12B ROCK1 TRIO ARHGEF1 CACNA1A CAMK2B PRKCB PRKCA VAV1 MYLK ARHGAP5 GNGT1 GNB1 MYL2 GNA12 GNA13 GNAQ PKN1 ARHGEF5 PLCB1 
29.387737,-18.72351,platelet amyloid precursor protein pathway,APP F11 SERPINE1 PLAU F2 PLAT PLG COL4A1 F9 COL4A3 COL4A2 COL4A5 COL4A4 COL4A6 
31.34945,-26.110424,polyadenylation of mrna,CPSF2 CPSF1 CPSF4 CSTF3 CPSF3 PABPN1 CSTF2 CSTF1 PAPOLA 
30.21019,-25.532606,prion pathway,LAMA3 LAMB3 HSPA5 LAMA2 LAMA5 PRNP LAMA4 LAMC1 LAMC3 LAMB2 LAMA1 LAMC2 LAMB1 GFAP RPSA DNAJB1P1 DNAJB6 BCL2 
31.310783,-19.562449,proteasome complex,PSMD11 PSMD12 PSMD14 RPN1 RPN2 UBE3A UBE2A PSMB7 PSMA6 PSMA7 PSMA4 PSMB5 PSMA5 PSMB6 PSMB3 PSMA2 PSMB4 PSMA3 PSMB1 PSMD3 PSMD4 PSMB2 PSMA1 UBA1 
32.54802,-25.4259,protein kinase a at the centrosome,RHOA PRKACG PRKAR2B PRKAR2A PRKCE AKAP9 PKN1 CDK1 PRKAG1 PPP2R5D PRKACB PPP1CA 
28.696575,-21.424654,proteolysis and signaling pathway of notch,NOTCH1 ADAM17 FURIN PSEN1 DLL1 RBPJ 
32.411278,-24.931581,pten dependent cell cycle arrest and apoptosis,ITGB1 CDKN1B SHC1 ILK PTEN FASLG FOXO3 PTK2 PIK3R1 PIK3CA AKT1 GRB2 BCAR1 PDK2 SOS1 
31.595478,4.383803,rac1 cell motility signaling pathway,RALBP1 PDGFRA MAP3K1 PPP1R12B LIMK1 CADM1 ARAP1 ARAP2 VAV1 ARFGAP3 ARFGAP1 PIK3R1 RPS6KB1 PIK3CA MYL2 CDK5 ARHGEF5 CDK5R1 NCF2 TRIO ARHGEF1 CACNA1A ASAP2 ARHGAP1 ARHGAP6 PLD1 ARHGAP4 MYLK ARHGAP5 PAK1 ASAP1 CHN1 CFL1 RAC1 ARFIP2 WASF1 
32.582695,-26.30935,ras signaling pathway,RHOA RALBP1 RALA CHUK BAD PDPK1 FOXO4 PLD1 VAV1 CDC42 CASP9 PIK3R1 PIK3CA BCL2L1 AKT1 RAC1 HRAS RALGDS RAF1 SOS1 
31.36905,-25.926985,ras-independent pathway in nk cell-mediated cytotoxicity,KLRC3 SYK MAP2K1 KLRC4 HLA-A IL18 VAV1 CD2 FCGR3A FCGR3B PAK1 PIK3R1 PIK3CA MAPK3 CD28 KLRD1 RAC1 KLRC1 KLRC2 B2M PTPN6 LAT 
30.202526,-23.818521,rb tumor suppressor/checkpoint signaling in response to dna damage,RB1 RASGRF1 CDKN1A MYT1 WEE1 CHEK1 CDK4 E2F1 CDK2 ATM CDK1 YWHAH TP53 
31.822508,-26.13519,regulation of bad phosphorylation,ADCY1 BAD PDPK1 IGF1 CSF2RB IGF1R IL3 PRKACG KITLG KIT PIK3R1 PIK3CA PRKAR1B PRKAR1A PRKAR2B IL3RA PRKAR2A BCL2L1 AKT1 BCL2 BAX PRKACB YWHAH 
30.178257,-20.686665,regulation of cell cycle progression by plk3,RASGRF1 APAF1 PLK3 CASP9 CCNB1 CASP6 CHEK1 CASP7 CHEK2 BAX CASP3 ATM TREX1 CDK1 CYCS YWHAH ATR TP53 
32.409855,-25.789415,regulation of ck1/cdk5 by type 1 glutamate receptors,ADCY1 CAMK2B PPP2R5D PPP1CA GRM1 PPP3CA GNGT1 PRKACG GNB1 PPP1R1B PRKAR1B CDK5 CSNK1D NCS1 PRKAR1A PRKAR2B PRKAR2A ADRBK1 GNAS DRD1 DRD2 PRKACB CDK5R1 PLCB1 
31.845457,-26.67536,regulation of eif-4e and p70s6 kinase,EIF4A1 IRS1 PDPK1 EIF4EBP1 PTEN PRKCB PRKCA MTOR GH1 PPP2CA MAPK14 GHR PSMC4 PIK3R1 RPS6KB1 PIK3CA MKNK1 AKT1 MAPK3 EIF4G1 PABPC1 MAPK1 EIF4E PDK2 
32.08728,-26.532423,regulation of eif2,EIF2B5 EIF5 GSK3B NPY4R EIF2AK2 EIF2AK1 EIF2AK4 EIF2AK3 EIF2S3 EIF2S2 EIF2S1 
31.825893,-25.021425,regulation of map kinase pathways through dual specificity phosphatases,DUSP6 DUSP4 MAPK8 DUSP1 DUSP2 MAPK3 DUSP9 DUSP8 MAPK14 
30.802456,-23.18883,regulation of p27 phosphorylation during cell cycle progression,RB1 CDKN1B CKS1B CUL1 NEDD8 RBX1 TFDP1 CCNE1 E2F1 CDK2 UBE2M SKP1 SKP2 
33.19617,-25.641306,regulation of pgc-1a,HDAC5 CAMK2D MEF2A ESRRA MEF2D MEF2C PPARA CAMK2A SLC2A14 CAMK2B MEF2BNB-MEF2B CAMKK1 CAMKK2 PPP3CA PPP3CB PPP3CC CAMK4 PPARGC1A CAMK2G YWHAH 
32.851387,-25.98785,regulation of spermatogenesis by crem,XPO1 GNGT1 GNB1 ADCY1 FSHB FSHR GNAS CREM FHL5 KIF17 
32.82932,-25.657719,regulation of splicing through sam68,KHDRBS1 RASA1 SRC MAP2K2 MAP2K1 MAPK3 CDK1 MAPK1 HRAS RAF1 
31.296888,-25.479212,regulation of transcriptional activity by pml,CREBBP RB1 UBE2I DAXX SP100 SUMO1 SIRT1 PAX3 TP53 PRAM1 PML 
31.713501,-25.318338,regulators of bone mineralization,COL4A1 COL4A3 COL4A2 COL4A5 ENPP1 COL4A4 IBSP ANKH ALPL COL4A6 SPP1 
31.75198,-26.387669,repression of pain sensation by the transcriptional regulator dream,JUN KCNIP3 OPRK1 FOS CREM PRKACG CREB1 POLR2A PRKAR1B RPS6KA3 PRKAR1A PRKAR2B PRKAR2A MAPK3 PRKACB 
32.497128,-25.005653,reversal of insulin resistance by leptin,PRKAA2 CPT1A LEP PRKAG2 LEPR PRKAG1 PRKAB1 PRKAB2 PRKAA1 ACACA 
32.490227,-25.505228,rho cell motility signaling pathway,GSN RHOA RALBP1 PPP1R12B LIMK1 ARAP1 ARAP2 VAV1 ARFGAP3 DIAPH1 ARFGAP1 MYL2 ARHGEF5 TLN1 PFN1 VCL ROCK1 NCF2 TRIO ARHGEF1 CACNA1A ASAP2 ARHGAP1 ARHGAP6 ARHGAP4 MYLK ARHGAP5 ASAP1 CHN1 PIP5K1A CFL1 PIP5K1B 
32.711906,-26.217209,rho-selective guanine exchange factor akap13 mediates stress fiber formation,AKAP13 RHOA PRKACG GNA12 PRKAR2B PRKAR2A LPAR2 LPAR3 PRKAG1 PRKACB LPAR1 
31.246216,-25.043827,rna polymerase iii transcription,SSB GTF3C3 GTF3C4 GTF3C5 BRF1 NR3C1 BDP1 GTF3C1 
31.476887,-26.150293,role of brca1 brca2 and atr in cancer susceptibility,HUS1 MRE11A FANCA BRCA1 BRCA2 FANCC FANCF RAD50 FANCE FANCG RAD51 CHEK1 FANCD2 CHEK2 NBN RAD17 ATM TREX1 RAD1 ATR TP53 RAD9A 
31.707666,-26.377747,role of egf receptor transactivation by gpcrs in cardiac hypertrophy,RHOA EDN1 EGF MAP2K2 JUN MAP2K1 CHUK ADAM12 FOS PRKCB PRKCA AGT NFKBIA GNB1 AGTR2 GRB2 RAF1 SOS1 RELA SHC1 EGFR GNGT1 EDNRA IKBKB EDNRB RPS6KA1 GNA11 MYC MAPK3 PLCG1 MAPK1 HRAS IKBKG 
31.366909,4.3219557,role of erbb2 in signal transduction and oncology,MAP2K2 MAP2K1 PDPK1 STAT3 ESR1 LRPPRC IL6 PIK3R1 PIK3CA CARM1 GRB2 RAF1 SOS1 SHC1 EGFR GRIP1 ERBB4 ERBB2 EP300 ERBB3 AKT1 MAPK3 MAPK1 HRAS JAK3 IL6R JAK1 JAK2 
29.453556,-24.901987,role of erk5 in neuronal survival pathway,MEF2A MAP2K5 MEF2D MAP2K2 NTRK1 MEF2C MAP2K1 PDPK1 BDNF NGF CREB1 PIK3R1 PIK3CA GRB2 RAF1 SOS1 SHC1 MEF2BNB-MEF2B RPS6KA1 NTF3 AKT1 MAPK3 PLCG1 MAPK1 HRAS MAPK7 
31.7531,-25.518751,role of mal in rho-mediated activation of srf,MAP4K2 RHOA MAP2K2 MAP3K1 ROCK1 LIMK1 MAP2K1 SRF CDC42 DIAPH1 ACTA1 MAPK8 HNF1A MAL MAPK3 RAC1 MAPK1 HRAS RAF1 
31.466434,-23.558857,role of mef2d in t-cell apoptosis,MEF2D PRKCB NFATC1 PRKCA ZAP70 PTPRC LCK CD4 HLA-DRA CD247 LAT HLA-DRB1 CABIN1 TRB TRA HDAC1 HDAC2 CAMK2B CD3G CD3E NR4A1 CD3D PPP3CA PPP3CB PPP3CC EP300 CAPNS1 PLCG1 CAPN2 FYN 
30.320068,-21.016117,role of mitochondria in apoptotic signaling,BIK DIABLO APAF1 CASP9 AIFM1 BCL2L1 BCL2 BAX CYCS BAK1 BID BIRC2 BIRC3 
32.175804,-26.352564,role of nicotinic acetylcholine receptors in the regulation of apoptosis,SRC BAD PDPK1 FASLG FOXO3 PTK2 PIK3R1 PIK3CA TERT CHRNG AKT1 PTK2B RAPSN MUSK YWHAH CHRNB1 AGRN 
32.385525,-26.67667,role of parkin in ubiquitin-proteasomal pathway,PARK2 GPR37 SUMO1 UBE2E2 UBE2G2 UBE2L6 UBE2G1 UBE2L3 
31.46672,4.2855253,role of pi3k subunit p85 in regulation of actin organization and cell migration,ARPC1A ACTR3 RHOA PDGFRA ACTR2 ARPC1B PDGFA WASL CDC42 PAK1 ARPC3 PIK3R1 PIK3CA ARPC4 ARPC2 RAC1 
32.03503,-25.697224,role of ppar-gamma coactivators in obesity and thermogenesis,NCOA2 MED1 CREBBP RXRA NCOA1 LPL EP300 PPARG PPARGC1A 
31.51948,-26.307262,role of ran in mitotic spindle regulation,RANBP2 KPNB1 TPX2 RANBP1 NUMA1 AURKA RCC1 KIF15 RAN KPNA2 RANGAP1 
33.23362,-11.378021,role of ﬂ-arrestins in the activation and targeting of map kinases,EDN1 MAP2K2 MAP2K1 F2 DNM1 AGT CXCL12 GNB1 AGTR2 GNAS RAF1 CHRM1 PTGER1 CCL11 HTR2C FPR1 ADRB2 ADRA1B GNGT1 EDNRA EDNRB ARRB1 CXCR4 P2RY2 ADRBK1 MAPK3 CCL4 MAPK1 CCR5 CCR3 
33.239445,-11.3702135,roles of ﬂ arrestin dependent recruitment of src kinases in gpcr signaling,EDN1 MAP2K2 MAP2K1 F2 DNM1 AGT HCK FGR CXCL12 GNB1 AGTR2 GNAS RAF1 SRC CHRM1 PTGER1 CCL11 HTR2C FPR1 ADRB2 ADRA1B GNGT1 EDNRA EDNRB ARRB1 CXCR4 P2RY2 ADRBK1 MAPK3 CCL4 MAPK1 HRAS CCR5 CCR3 
28.907917,-22.054918,segmentation clock,FZD1 HES7 NOTCH1 GSK3B CSNK2A1 CTNNB1 LRP6 KREMEN2 AXIN1 PSEN1 DLL1 DKK1 DKK2 NKD1 NKD2 RBPJ PROC LFNG ADAM17 HEY2 WIF1 DVL1 WNT1 HES1 
32.27924,-25.775444,signal dependent regulation of myogenesis by corepressor mitr,MEF2A MEF2D MEF2C CAMK2B MYOD1 HDAC9 MEF2BNB-MEF2B YWHAH 
31.83286,-24.813953,signal transduction through il1r,TGFB1 TGFB3 MAP3K1 MAP2K3 TGFB2 JUN IL1R1 CHUK FOS MAPK14 IL1A IL1B MYD88 NFKBIA IL6 ECSIT TOLLIP TRAF6 TAB2 TAB1 IL1RN RELA IFNA1 PEBP1 IL1RAP TNF IKBKB MAPK8 IRAK2 IRAK3 IRAK1 IFNB1 MAP3K7 IKBKG MAP4K4 MAP2K6 
30.756937,-24.113548,signaling pathway from g-protein families,MAP2K1 PRKCB NFATC1 PRKCA CREB1 GNB1 PRKAR1B PRKAR1A GNAQ GNAS RAF1 CAMK2B ELK1 GNAI1 PPP3CA GNGT1 PPP3CB PRKACG PPP3CC RPS6KA3 PRKAR2B PRKAR2A MAPK3 PLCG1 HRAS PRKACB 
32.175793,-26.422165,skeletal muscle hypertrophy is regulated via akt-mtor pathway,EIF2B5 PDPK1 RPS6 IGF1 PPP2R5D EIF2S3 EIF2S2 MTOR EIF2S1 PSMC4 PIK3R1 RPS6KB1 PIK3CA EIF4G1 PABPC1 EIF4A1 GSK3B EIF4EBP1 PTEN INPPL1 IGF1R MKNK1 AKT1 EIF4E PDK2 
29.685518,-23.329601,sodd/tnfr1 signaling pathway,MADD BAG4 CRADD TRADD TNF TRAF2 RIPK1 TNFRSF1A BIRC3 
31.997267,-26.012589,sonic hedgehog receptor ptc1 regulates cell cycle,XPO1 SHH CDK7 CCNB1 RASGRF1 CCNH CDK1 PTCH1 MNAT1 
31.871286,-26.950693,spliceosomal assembly,SNRPA SNRNP70 SRSF2 U2AF2 SNRPB2 SNRPA1 U2AF1 SNRPC 
29.127441,-24.01011,sprouty regulation of tyrosine kinase signals,SRC EGF MAP2K2 SHC1 MAP2K1 SH3KBP1 CBL EGFR RASA1 PTPRB MAPK3 SPRY4 SPRY3 SPRY2 MAPK1 HRAS SPRY1 GRB2 RAF1 SOS1 
31.835371,-26.246162,srebp control of lipid synthesis,MBTPS1 SREBF1 MBTPS2 SREBF2 HMGCS1 SCAP LDLR 
31.029966,-25.339228,stat3 signaling pathway,STAT3 MAPK3 MAPK1 JAK3 TYK2 MTOR JAK1 JAK2 
31.613218,-25.554344,stathmin and breast cancer resistance to antimicrotubule agents,CAMK2D CAMK2A CAMK2B TUBB1 TUBA1A TUBA3C MAPK13 TUBA4B TUBA4A TUBA8 CD2 PRKACG TUBA1C CCNB1 PRKAR1B STMN1 PRKAR1A PRKAR2B PRKAR2A CDK1 CAMK4 CD247 PRKACB CAMK2G 
31.599466,-25.692806,stress induction of hsp regulation,DAXX APAF1 TNF FASLG HSPB1 IL1A ACTA1 CASP9 MAPKAPK2 FAS MAPKAPK3 BCL2 CASP3 CYCS 
31.388374,-19.642942,sumoylation as a mechanism to modulate ctbp-dependent gene responses,ZEB1 SUMO1 CTBP1 CDH1 UBE3A NOS1 UBE2A UBA1 
32.03964,-25.511717,sumoylation by ranbp2 regulates transcriptional repression,HDAC6 RANBP2 HDAC4 HDAC1 NUP214 NUP153 NUP210 PIAS1 HDAC9 PIAS2 SUMO1 NUP62 RAN MDM2 
31.981186,-24.931068,t cell receptor signaling pathway,RALBP1 MAP3K1 TEC CD4 PTPN7 PDCD1 PTPN6 RAF1 RELA CSF2 CBLC ASAP2 TNF CBLB NRAS PAK2 PAK1 ASAP1 AKT3 AKT1 PAK7 AKT2 GRAP2 PAK4 PAK3 MAP3K8 PAK6 MAP2K4 CARD11 MAP2K1 PRKCB PRKCA NFKB1 NFKB2 ARFGAP3 ARFGAP1 PIK3R1 CD8B CD8A PRKCQ GRB2 MAP3K14 HLA-DRB1 NCF2 BCL10 ARHGAP1 ARHGAP6 ELK1 ARHGAP4 ARHGAP5 PPP3R1 RASGRP1 PPP3R2 PLCG1 PDK1 RHOA IL10 JUN NFATC4 NFATC3 NFATC2 ARAP1 NFATC1 ARAP2 VAV1 VAV2 VAV3 IL2 NFKBIB IL5 IL4 NFKBIA PTPRC PIK3CB PIK3CA CDK4 IFNG HLA-DRA CD28 LCP2 CD247 SOS2 NFKBIE ITK LAT SOS1 NFAT5 TRB TRA SHC1 PIK3R5 PIK3R3 PIK3R2 CD3G CD3E CD3D PPP3CA PPP3CB PPP3CC CTLA4 ICOS CHUK FOS CDC42 ZAP70 LCK KRAS CD40LG CAMK2B PIK3CD CBL PIK3CG MALT1 IKBKB MAPK8 CHN1 MAPK3 RAC1 HRAS FYN IKBKG NCK1 NCK2 
32.194714,-25.660353,telomeres telomerase cellular aging and immortality,RB1 XRCC5 XRCC6 TNKS TERF1 PRKCA PPP2R5D POLR2A TERT TEP1 MYC AKT1 BCL2 KRAS TP53 
31.691536,-25.888617,tgf beta signaling pathway,TGFB1 ACVR1 TGFB3 TGFB2 PPP2R1A RBX1 ZFYVE16 ROCK1 ZFYVE9 ROCK2 TNF COMP CDH1 MYC E2F4 E2F5 MAP3K7 PITX2 SMAD3 CREBBP SMAD2 SMAD5 SMAD4 MAP2K1 SMAD1 FST INHBA GDF5 INHBC INHBB INHBE GDF7 SMAD7 GDF6 SMAD6 SMAD9 PROC TFDP1 TAB1 NODAL AMHR2 CUL1 CHRD LTBP1 SKP1 RHOA SMURF2 SMURF1 BMP8B BMP8A TGFBR1 BMP7 TGFBR2 ACVR2B ACVR2A BMP6 BMP5 BMP4 RBL1 SP1 BMP2 RBL2 ID1 ID3 IFNG ID2 ID4 BMPR1A BMPR1B ACVRL1 BMPR2 SAR1A NR2C2 AMH SKIL LEFTY2 LEFTY1 NOG CDKN2B PPP2CA DCN RPS6KB2 RPS6KB1 PPP2R2C THBS1 PPP2R2B PPP2R2A ACVR1C THBS3 ACVR1B THBS2 THBS4 PPP2CB PPP2R1B EP300 MAPK3 MAPK1 
30.18096,-24.950617,the 41bb-dependent immune response,ATF2 RELA MAP2K3 JUN TRAF2 IL2 MAPK14 IL4 IFNG TNFRSF9 TNFSF9 MAP3K5 MAP2K6 
30.577812,-26.053902,the co-stimulatory signal during t-cell activation,CD86 TRB TRA CD80 PTPN11 CD3G CD3E CD3D LCK PIK3R1 PIK3CA HLA-DRA CD28 CTLA4 GRB2 CD247 ITK ICOS ICOSLG HLA-DRB1 
32.129627,-26.466824,the igf-1 receptor and longevity,IRS1 SHC1 PDPK1 IGF1 SOD3 FOXO3 IGF1R SOD1 SOD2 CAT PIK3R1 PIK3CA AKT1 HRAS GRB2 SOS1 
31.455574,4.459105,the information processing pathway at the ifn beta enhancer,CREBBP SMARCC1 SMARCC2 JUN SMARCE1 GTF3A ARID1A GTF2F1 SMARCA4 IRF1 KAT2B IRF4 IRF5 IRF2 IRF3 IRF6 IRF7 ATF2 GTF2A1 SMARCD1 RELA SMARCB1 GTF2B HMGB1 GTF2E1 NR3C1 ACTB POLR2A IFNB1 
32.448883,-25.665638,the prc2 complex sets long-term gene silencing through modification of histone tails,PHC1 SUZ12 EED HDAC1 CBX4 HDAC2 RING1 H3F3A H3F3B BMI1 YY1 RBBP4 RBBP7 EZH2 
31.553541,3.8507679,thrombin signaling and protease-activated receptors,ARFGEF2 RHOA PPP1R12B ARFGEF1 F2R GBF1 PRKCB F2 PRKCA GNB1 PIK3R1 PIK3CA GNAQ F2RL3 PLCB1 ROCK1 ADCY1 GNAI1 CYTH4 CYTH3 GNGT1 GNA12 GNA13 PTK2B MAP3K7 CYTH2 CYTH1 
29.868107,-24.863241,tnf/stress related signaling,MAP2K4 MAP4K2 MAP3K1 MAP2K3 JUN ATF1 CHUK CRADD TRADD TNF TRAF2 TNFRSF1A TANK MAPK14 IKBKB MAPK8 BAG4 CASP2 RIPK1 IKBKG MAP4K4 MAP2K6 MAP2K7 
29.667444,-23.33259,tnfr1 signaling pathway,MAP2K4 CRADD TRADD LMNB1 TNF TRAF2 TNFRSF1A LMNB2 MADD LMNA CASP8 BAG4 CASP2 CASP3 FADD RIPK1 BIRC3 
32.147675,-26.204351,tnfr2 signaling pathway,NFKBIA RELA MAP3K1 TRAF1 TNFAIP3 LTA TRAF3 TRAF2 RIPK1 MAP3K14 TANK TNFRSF1B 
31.765774,-24.587044,toll-like receptor pathway,MAP2K4 MAP3K1 MAP2K3 JUN PPARA CHUK EIF2AK2 FOS TIRAP MAPK14 TLR2 MYD88 NFKBIA ECSIT TOLLIP TRAF6 TLR9 TLR7 TAB2 TLR6 MAP3K14 TAB1 TLR4 TLR3 RELA LY96 ELK1 IKBKB MAPK8 IRAK1 CD14 MAP3K7 IKBKG PGLYRP1 MAP2K6 
30.962833,-23.847618,tpo signaling pathway,STAT5B JUN STAT1 SHC1 CSNK2A1 MAP2K1 STAT3 FOS MPL PRKCB PRKCA ELK1 RASA1 PIK3R1 PIK3CA THPO MAPK3 PLCG1 HRAS GRB2 STAT5A RAF1 SOS1 JAK2 
31.125423,-24.127115,transcription factor creb and its extracellular signals,PDPK1 PRKCB PRKCA MAPK14 CREB1 PIK3R1 PIK3CA PRKAR1B PRKAR1A GNAS GRB2 SOS1 CAMK2D SHC1 CAMK2A CAMK2B RPS6KA5 PRKACG RPS6KA1 PRKAR2B PRKAR2A AKT1 MAPK3 MAPK1 HRAS PRKACB CAMK2G 
31.05394,-25.675812,transcription regulation by methyltransferase of carm1,CREBBP NCOA3 PRKACG RXRA CREB1 PRKAR1B PRKAR1A PRKAR2B EP300 PRKAR2A BCL2 CARM1 RARA PRKACB 
32.486374,-26.088331,trefoil factors initiate mucosal healing,RHOA MAP2K2 MAP2K1 APAF1 CHUK BAD PDPK1 GH1 NFKBIA PIK3R1 PIK3CA TFF3 CYCS TFF2 TFF1 GRB2 RAF1 SOS1 RELA SHC1 CTNNB1 EGFR IKBKB GHR MUC2 CASP9 RPS6KA1 CASP6 CASP7 ERBB2 AKT1 MAPK3 CASP3 MAPK1 HRAS IKBKG 
31.848293,-25.996202,trka receptor signaling pathway,NTRK1 SHC1 PDPK1 PRKCB PRKCA NGF PIK3R1 PIK3CA AKT1 PLCG1 HRAS GRB2 SOS1 
32.45483,-26.753086,tsp-1 induced apoptosis in microvascular endothelial cell,JUN GZMA FOS CASP3 FYN CD36 MAPK14 
31.469948,-25.05788,tumor suppressor arf inhibits ribosomal biogenesis,TBX2 RB1 HSP90AA1 CDKN2A UBE2A TWIST1 NFKBIB DNAJB1P1 POLR1A PIK3R1 POLR1B PIK3CA POLR1C E2F1 POLR1D MYC AKT1 HSPA1A ATM RAC1 ABL1 TP53 MDM2 
32.185646,-25.889297,ucalpain and friends in cell spread,ITGA1 ITGB1 RHOA SRC PXN ACTN4 ACTN3 ACTN2 ACTN1 PTK2 ACTA1 CAPNS1 RAC1 CAPN1 SPTAN1 TLN1 EZR 
31.624481,3.831188,vegf hypoxia and angiogenesis,HSP90AA1 NOS3 PDPK1 CAV1 ARNT PRKCB PRKCA VEGFA PTK2 ACTA1 PIK3R1 PIK3CA GRB2 BCAR1 SOS1 SRC FLT1 SHC1 PXN FLT4 CAMK2B HIF1A KNG1 AKT1 VHL KDR BDKRB2 PLCG1 HRAS CSK 
31.76886,-25.853254,visceral fat deposits and the metabolic syndrome,ADIPOQ RXRA LPL PPARG RETN TNF NR3C1 HSD11B1 
31.915659,-25.800726,visual signal transduction,RCVRN PDE6G GUCA1A GNGT2 GRK1 SLC25A18 GNB1 ARRB1 RHO SLC25A22 GNAT1 PDE6B PDE6A 
30.159218,-20.645939,west nile virus,TIAL1 EEF1A1 CASP9 TIA1 CASP6 APAF1 CASP7 CASP3 CYCS 
28.890997,-22.109833,wnt lrp6 signalling,FZD1 LRP6 KREMEN2 WNT8B WNT8A DKK1 DKK2 
29.185514,-22.306513,wnt signaling pathway,TLE1 FBXW11 CTNNBIP1 WNT5A WNT5B PPP2R1A DKK1 DKK2 RBX1 DKK4 SFRP4 SFRP5 TBL1XR1 SFRP2 MAPK10 APC TP53 LEF1 ROCK1 ROCK2 LRP6 LRP5 FZD10 PRKY PRKX NKD1 SFRP1 NKD2 RUVBL1 FRAT1 FRAT2 CCND3 CCND2 WIF1 CCND1 MYC TBL1X TBL1Y MAP3K7 BTRC CER1 SMAD3 FZD2 SIAH1 CREBBP FZD1 SMAD2 PRKCG FZD4 WNT10B WNT10A FZD3 SMAD4 WNT3A FZD6 FZD5 FZD8 FZD7 KREMEN2 FZD9 CSNK1E PRKCA VANGL2 PROC VANGL1 FOSL1 HNF1A CSNK2B TCF7 TAB1 WNT2B CTBP2 CTBP1 CUL1 PSEN1 NLK PORCN PPP3R1 PRKACG PPP3R2 SOX17 PRKACB SKP1 PRKACA RHOA MMP7 CSNK1A1 JUN NFATC4 AXIN2 NFATC3 AXIN1 WNT9A NFATC2 NFATC1 WNT9B PPP2R5D WNT16 SENP2 NFAT5 GSK3B CHD8 WNT8B WNT8A WNT6 PPP3CA PPP3CB WNT11 PPP3CC DVL1 DVL2 DVL3 WNT1 WNT2 WNT3 WNT4 TCF7L2 TCF7L1 APC2 CSNK2A2 CSNK2A1 WNT7A WNT7B CACYBP PPP2CA CSNK1A1L PLCB4 DAAM2 PPP2R2C DAAM1 PLCB2 PLCB3 PPARD PLCB1 CAMK2D HDAC1 CTNNB1 CAMK2A CAMK2B CXXC4 PRICKLE1 PPP2R2B PRICKLE2 PPP2R2A PPP2CB MAPK9 MAPK8 PPP2R1B EP300 RAC3 RAC1 RAC2 CAMK2G 
32.221813,-25.262913,y branching of actin filaments,ARPC1A ACTR3 ACTR2 NCKAP1 ARPC1B WASL CDC42 PSMA7 ARPC3 ARPC4 ARPC2 ABL2 PIR RAC1 WASF2 NCK1 
32.118465,-26.410076,yaci and bcma stimulation of b cell immune responses,TRAF5 TNFRSF13B TNFSF13 TRAF6 TNFRSF17 TRAF3 TRAF2 TNFSF13B 
33.218193,-11.392201,ﬂ-arrestins in gpcr desensitization,EDN1 PPARA F2 DNM1 AGT CXCL12 GNB1 AGTR2 GNAS CHRM1 PTGER1 CCL11 HTR2C FPR1 ADRB2 AP2A1 ADRA1B GNGT1 EDNRA EDNRB ARRB1 CXCR4 P2RY2 ADRBK1 CCL4 CCR5 CCR3 AP2M1 
